Trial Profile
Long Term Hepatitis A Virus (HAV) Antibody Persistence in Children Vaccinated With 1 Dose and Those Vaccinated With 2 Doses of Havrix in Panama
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 07 Sep 2018 Status changed from recruiting to completed.
- 08 May 2018 Planned number of patients changed from 600 to 1200.
- 12 Jan 2018 Planned End Date changed from 20 Mar 2020 to 1 Apr 2019.